21-Apr-10 12:00 PM  CST

The AstraZeneca HealthCare Foundation Launches Grant Program for Cardiovascular Health

WILMINGTON, Del.--Building connections with patients and improving collaboration between them and their caregivers are what the AstraZeneca HealthCare Foundation hopes to achieve with its newest grant program aimed at improving cardiovascular health.  

Connections for Cardiovascular Health will award $150,000 and up annually to U.S. nonprofit organizations doing innovative work on the grassroots level to improve cardiovascular health in the United States. Even though brilliant innovations are being made every day in cardiovascular science, the World Health Organization reports that cardiovascular disease is still the leading cause of death in both the United States and the world. The AstraZeneca HealthCare Foundation, established in 1993 and a separate entity from the pharmaceutical company AstraZeneca, believes one of the reasons for this disconnect is that patients suffering from cardiovascular disease are still not well-connected with the treatments they need. Dr. James Blasetto, chairman of the AstraZeneca HealthCare Foundation, believes that the greatest difference in improving cardiovascular health lies with programs that helps connect patients with the care they need.

"We believe that to make a difference and help patients live healthier lives, we need to form connections with those who are working to address cardiovascular health care needs in the community," Blasetto said in a media release.

AstraZeneca announced its support for the new grant program with a donation of $25 million to help fund the grants.

“At AstraZeneca, we believe that a healthier world cannot come from medicine alone but also through collaboration with our stakeholders,” said Tiffany Burke, the media representative for AstraZeneca in the U.S.

Grant applications will be judged by the AstraZeneca HealthCare Board of Trustees, which includes some of the nation’s leading representatives in cardiovascular care, such as Michael Miller, MD, FACC, FAHA of the University of Maryland and senior author of a new book; John Buse, MD, PhD of the University of North Carolina and a past President for Medicine and Science at the American Diabetes Association; Jennifer H. Mieres, MD, FACC, FASNC, FAHA of the New York University School of Medicine and Advisory Board member for WomenHeart (the national coalition for women living with heart disease); and Timothy J. Gardner, MD of Christiana Care’s Center for Heart & Vascular Health and immediate past president of the American Heart Association.

Nonprofit organizations interested in applying should  visit www.astrazeneca-us.com for more information. Award recipients will be notified in November of this year. The deadline to apply is July 31, 2010.

Copyright © 2010 NPTA. All rights reserved.

For additional information on this article, please contact:
Kristina Michel
(888) 247-8700
Source: NPTANews  

Tendenci™ User Home © 2004 Tendenci™ software by Schipul - "The Web Marketing Company" | www.schipul.com